Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Carcinoma, Non-small-cell Lung Cancer or Lung Neoplasms
and you are
between 18 and 80
years old
-
The phase for this study is not defined.
Show me locations

The purpose

This study will evaluate the feasibility and effectiveness of urinary ctDNA detection and dynamic monitoring during treatment of NSCLC patients prospectively,by collecting and detecting tumor tissues, peripheral blood samples and urine samples of NSCLC patients.
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02907606. The sponsor of the trial is Peking University People's Hospital and it is looking for 45 volunteers for the current phase.
Official trial title:
Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study